Insider Transactions in Q1 2025 at Cerus Corp (CERS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2025
|
William Mariner Greenman President and CEO |
SELL
Open market or private sale
|
Direct |
60,984
-1.4%
|
$60,984
$1.5 P/Share
|
|
Mar 07
2025
|
Vivek K Jayaraman Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
33,999
-2.21%
|
$33,999
$1.5 P/Share
|
|
Mar 07
2025
|
Chrystal Menard Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
27,457
-3.19%
|
$27,457
$1.5 P/Share
|
|
Mar 07
2025
|
Richard J Benjamin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,139
-3.44%
|
$26,139
$1.5 P/Share
|
|
Mar 07
2025
|
Kevin Dennis Green Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
31,148
-3.22%
|
$31,148
$1.5 P/Share
|
|
Mar 06
2025
|
William Mariner Greenman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,140,742
+11.24%
|
-
|
|
Mar 06
2025
|
Vivek K Jayaraman Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
635,486
+16.43%
|
-
|
|
Mar 06
2025
|
Chrystal Menard Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
454,577
+20.12%
|
-
|
|
Mar 06
2025
|
Richard J Benjamin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
366,565
+19.11%
|
-
|
|
Mar 06
2025
|
Kevin Dennis Green Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
473,040
+19.19%
|
-
|
|
Mar 04
2025
|
Vivek K Jayaraman Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,780
-1.18%
|
$10,780
$1.55 P/Share
|
|
Mar 04
2025
|
Chrystal Menard Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
66,292
-7.12%
|
$66,292
$1.57 P/Share
|
|
Mar 04
2025
|
Kevin Dennis Green Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,386
-1.49%
|
$8,386
$1.55 P/Share
|
|
Mar 04
2025
|
William Mariner Greenman President and CEO |
SELL
Open market or private sale
|
Direct |
23,023
-0.71%
|
$23,023
$1.55 P/Share
|
|
Mar 04
2025
|
Richard J Benjamin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,292
-1.57%
|
$6,292
$1.55 P/Share
|
|
Mar 03
2025
|
Vivek K Jayaraman Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,850
+2.54%
|
-
|
|
Mar 03
2025
|
Chrystal Menard Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,912
+2.87%
|
-
|
|
Mar 03
2025
|
Kevin Dennis Green Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
60,656
-10.94%
|
$60,656
$1.58 P/Share
|
|
Mar 03
2025
|
Kevin Dennis Green Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,550
+3.19%
|
-
|
|
Mar 03
2025
|
William Mariner Greenman President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
57,637
+1.74%
|
-
|
|
Mar 03
2025
|
Richard J Benjamin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
51,254
-11.34%
|
$51,254
$1.58 P/Share
|
|
Mar 03
2025
|
Richard J Benjamin Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,912
+2.99%
|
-
|